Instituto Oncologico Veneto IRCCS

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Melanoma1 trial
• Pancreatic cancer1 trial

Phase

• Phase 32 trials

Status

• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• ETOP IBCSG Partners Foundation1 trial
• Revolution Medicines, Inc.1 trial

Running trials

• Recruiting

  Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  NCT07621718· Phase 3· Revolution Medicines, Inc.· Source

  Contact: Revolution Medicines Study Director

• Recruiting

  Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

  NCT05522660· Phase 3· ETOP IBCSG Partners Foundation· Source

  Contact: Luisa Piccin

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Melanoma1 recruiting
• Pancreatic cancer1 recruiting